PreludeDx

PreludeDx delivers actionable tools to manage early stage breast cancer for patients and their physi

09/03/2026

When a woman is diagnosed with DCIS, everything can move very quickly—and she may not know what questions to ask.

In this conversation, Learn Look Locate founder Cynthia Jordan speaks with PreludeDx CEO Dan Forche about how DCISionRT® provides personalized information about recurrence risk and radiation benefit to help women and their physicians make more informed treatment decisions.

Most importantly, women need to know this test exists—and that they can ask their doctors about it.

Watch the video, then visit Learn Look Locate’s dedicated resource on DCIS and DCISionRT: https://bit.ly/4gJkzwZ

09/01/2026

“I couldn’t find the book I needed, so I wrote it.”

When Jennifer Douglas was diagnosed with DCIS, she struggled to find a resource that spoke to the uncertainty, fear and complicated emotions surrounding the diagnosis.

That experience inspired her to write A Breast Cancer Journey—a step-by-step companion created to help other women feel informed, supported and less alone.

We’re proud to support Jennifer and her work as a DCIS patient advocate. Thank you, OncoDaily, for highlighting her story and the meaningful difference patient voices can make.

Read more: https://bit.ly/4xA0HDT

08/27/2026

“This is a game of clarity, so patients know what choice they’re making.”

For breast surgeon Dr. Erica Giblin, education and individualized information are essential to helping patients make confident decisions about DCIS treatment.

In this Game Changers with Hannah Storm interview, Dr. Giblin shares how DCISionRT® helps bring facts and clarity to the conversation—helping physicians and patients understand the benefit of radiation and make more informed, personalized treatment decisions.

🎥 Watch the full conversation: https://bit.ly/4hWeyQ2

08/25/2026

Looking for a doctor who offers DCISionRT but not sure where to start? We’d love to help.

There’s a map on our website that shows where physicians are who order the test. Once you find a location near you, click on the link, fill out the form and we’ll help you connect.

Just click here! https://bit.ly/4jYoDKh

08/19/2026

"I want information about this cancer—not somebody else's cancer." — Dr. Janie Grumley

Every breast cancer diagnosis is unique. So why should treatment decisions be based on averages?

In her conversation with Hannah Storm, breast surgeon Dr. Janie Grumley of Saint John's Cancer Institute explains why not every patient with DCIS benefits from radiation therapy—and why personalized information about an individual patient's tumor can help identify who is more likely to benefit.

Hear why she calls DCISionRT® "life-changing," helping physicians make more confident recommendations and giving patients the confidence to move forward with a treatment plan they can trust.

🎥 Watch the full interview https://bit.ly/4hDOhFS

08/11/2026

Could GLP-1 medications affect breast cancer risk or outcomes?

New research presented at ASCO 2026 is raising questions about Ozempic, Wegovy, Mounjaro, Zepbound and other GLP-1 medications—and their potential impact beyond weight loss.

The research is raising intriguing questions about breast cancer risk, treatment outcomes and survivorship. The findings are promising, but it’s still early, and more research is needed.

For people living with breast cancer or navigating survivorship, understanding what we know—and what we don’t—is important.

Read the latest from Surviving Breast Cancer: GLP-1 Medications and Breast Cancer: What the Latest Research Really Means https://bit.ly/4fR5N8n

08/06/2026

"I thought having a physician as a husband would make it easier to navigate my cancer journey. But it didn’t. He was as overwhelmed as I was." — Britta, breast cancer survivor

Even with medical knowledge and experience, a breast cancer diagnosis brings difficult decisions.

After her Stage I invasive ductal carcinoma diagnosis, Britta used AidaBreast® to better understand her individual risk of recurrence and benefit from radiation therapy.

The results helped her and her physicians make a more informed treatment decision—and move forward with confidence.

Read Britta’s story and learn how AidaBreast helped guide her treatment journey: https://bit.ly/4hfmOKx

Thank you, Britta, for sharing your story and helping others understand the value of personalized breast cancer care.

08/04/2026

"We don't treat cancers. We treat patients."

In the latest Conversations with Hannah Storm, radiation oncologist Dr. Rakesh Patel from Good Samaritan Hospital, shares why shared decision-making is one of the most important parts of breast cancer care—and why having personalized biological information, like DCISionRT, helps physicians and patients make more confident treatment decisions together.

“It's about giving the right treatment at the right time to the right patient."

Watch this thoughtful conversation with Hannah Storm to hear why shared decision-making isn't just good medicine—it's what every patient deserves.

🎥 Click here to watch: https://bit.ly/4xjg0jC

07/28/2026

Episode 4 of Conversations with Hannah Storm is LIVE.

"Radiation therapy can be very effective... but it's not necessary for everyone."

That's the message from breast surgeon Dr. Barry Rosen of Advocate Medical Group in this thoughtful conversation with Hannah Storm.

For years, many women with DCIS have been treated using a one-size-fits-all approach. But as Dr. Rosen explains, breast cancer care has evolved. Today, precision medicine can help identify which patients are most likely to benefit from radiation—and which may be able to safely avoid it
In this episode,

Dr. Rosen discusses:
✔️ The three things every woman should know about DCIS
✔️ Why personalized information can lead to better, more confident treatment decisions
✔️ Why he calls DCISionRT® "transformative" and says it gives patients clarity

🎥 Watch this powerful conversation and learn why personalized treatment matters. https://bit.ly/4b8HpfG

07/16/2026

Fear and anxiety are often the first emotions women experience after hearing the words, "You have breast cancer."

In Part 3 of our Conversations with Hannah Storm series, Dr. Lauren Kopicky of Cleveland Clinic discusses how education and personalized information can help change that experience for women diagnosed with DCIS.

By providing individualized risk information, DCISionRT® helps physicians have more meaningful conversations with patients—giving them a clearer understanding of their diagnosis and greater confidence in making treatment decisions together.

Because when patients understand their unique risk, they can move forward with knowledge instead of fear.

🎥 Watch the full interview. https://bit.ly/4vuRKtL

Address

26051 Merit Circle Suite 103
Laguna Hills, CA
92653

Website

http://www.preludedx.com/

Alerts

Be the first to know and let us send you an email when PreludeDx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to PreludeDx:

Want your business to be the top-listed Business in Laguna Hills?